U.S. pharma big copyright scrapped two experimental weight loss supplements final yr—a the moment-daily capsule, lotiglipron, on account of elevated liver enzymes along with a twice-everyday pill, danuglipron, due to strong side effects—but CEO Albert Bourla has mentioned the company